The estimated Net Worth of Stephen L Silvestro is at least $2 Milione dollars as of 2 May 2024. Mr. Silvestro owns over 90,000 units of OptimizeRx Corp stock worth over $788,140 and over the last 6 years he sold OPRX stock worth over $0. In addition, he makes $1,210,200 as Chief Commercial Officer at OptimizeRx Corp.
Stephen has made over 12 trades of the OptimizeRx Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 90,000 units of OPRX stock worth $655,200 on 2 May 2024.
The largest trade he's ever made was exercising 90,000 units of OptimizeRx Corp stock on 2 May 2024 worth over $655,200. On average, Stephen trades about 10,337 units every 57 days since 2019. As of 2 May 2024 he still owns at least 108,261 units of OptimizeRx Corp stock.
You can see the complete history of Mr. Silvestro stock trades at the bottom of the page.
Stephen L. Silvestro serves as Chief Commercial Officer of the Company. Mr. Silvestro was with CCH® Tagetik as its Vice President and General Manager from January 2018 until he joined us. From April 2017 to January 2018, Mr. Silvestro was with Prognos as its Chief Commercial Officer and, before that, from September 2007 to April 2017, he was with Decision Resources Group in various capacitates with him last serving as Executive Vice President, Head of Global Sales. Aside from that provided above, Mr. Silvestro does not hold and has not held over the past five years any other directorships in any company with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.
As the Chief Commercial Officer of OptimizeRx Corp, the total compensation of Stephen Silvestro at OptimizeRx Corp is $1,210,200. There are no executives at OptimizeRx Corp getting paid more.
Stephen Silvestro is 42, he's been the Chief Commercial Officer of OptimizeRx Corp since 2019. There are 13 older and no younger executives at OptimizeRx Corp. The oldest executive at OptimizeRx Corp is Gus Halas, 69, who is the Chairman of the Board.
Stephen's mailing address filed with the SEC is C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02453.
Over the last 2001 years, insiders at OptimizeRx Corp have traded over $20,012,815 worth of OptimizeRx Corp stock and bought 258,753 units worth $1,128,145 . The most active insiders traders include Investment Company, Inc. Awm, Bradley Louis Radoff e David Harrell. On average, OptimizeRx Corp executives and independent directors trade stock every 32 days with the average trade being worth of $183,485. The most recent stock trade was executed by Patrick D Spangler on 5 June 2024, trading 10,061 units of OPRX stock currently worth $73,244.
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
OptimizeRx Corp executives and other stock owners filed with the SEC include: